» Articles » PMID: 33603755

Legend of the Sentinels: Development of Lung Resident Memory T Cells and Their Roles in Diseases

Overview
Journal Front Immunol
Date 2021 Feb 19
PMID 33603755
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

SARS-CoV-2 is wreaking havoc around the world. To get the world back on track, hundreds of vaccines are under development. A deeper understanding of how the immune system responds to SARS-CoV-2 re-infection will certainly help. Studies have highlighted various aspects of T cell response in resolving acute infection and preventing re-infections. Lung resident memory T (T) cells are sentinels in the secondary immune response. They are mostly differentiated from effector T cells, construct specific niches and stay permanently in lung tissues. If the infection recurs, locally activated lung T cells can elicit rapid immune response against invading pathogens. In addition, they can significantly limit tumor growth or lead to pathologic immune responses. Vaccines targeting T cells are under development, with the hope to induce stable and highly reactive lung T cells through mucosal administration or "prime-and-pull" strategy. In this review, we will summarize recent advances in lung T cell generation and maintenance, explore their roles in different diseases and discuss how these cells may guide the development of future vaccines targeting infectious disease, cancer, and pathologic immune response.

Citing Articles

The role of metagenomic next-generation sequencing in diagnosing and managing post-kidney transplantation infections.

Wu H, Cao H, Gao X, Shi C, Wang L, Gao B Front Cell Infect Microbiol. 2025; 14():1473068.

PMID: 39839264 PMC: 11747774. DOI: 10.3389/fcimb.2024.1473068.


A vaccine platform targeting lung-resident memory CD4 T-cells provides protection against heterosubtypic influenza infections in mice and ferrets.

Ko K, Bae H, Park J, Lee J, Park S, Heo J Nat Commun. 2024; 15(1):10368.

PMID: 39609429 PMC: 11604757. DOI: 10.1038/s41467-024-54620-4.


Lung Immune Cell Niches and the Discovery of New Cell Subtypes.

Shan Q, Qiu J, Dong Z, Xu X, Zhang S, Ma J Adv Sci (Weinh). 2024; 11(45):e2405490.

PMID: 39401416 PMC: 11615829. DOI: 10.1002/advs.202405490.


SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.

Hsieh M, Hsu C, Liao H, Lin C, Chiang C, Chen M J Virol. 2024; 98(2):e0154623.

PMID: 38299865 PMC: 10878263. DOI: 10.1128/jvi.01546-23.


Comprehensive immune landscape of lung-resident memory CD8 T cells after influenza infection and reinfection in a mouse model.

Jia J, Li H, Huang Z, Yu J, Zheng Y, Cao B Front Microbiol. 2023; 14:1184884.

PMID: 37415817 PMC: 10320391. DOI: 10.3389/fmicb.2023.1184884.


References
1.
Wakim L, Gupta N, Mintern J, Villadangos J . Enhanced survival of lung tissue-resident memory CD8⁺ T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol. 2013; 14(3):238-45. DOI: 10.1038/ni.2525. View

2.
Hombrink P, Helbig C, Backer R, Piet B, Oja A, Stark R . Programs for the persistence, vigilance and control of human CD8 lung-resident memory T cells. Nat Immunol. 2016; 17(12):1467-1478. DOI: 10.1038/ni.3589. View

3.
Channappanavar R, Fett C, Zhao J, Meyerholz D, Perlman S . Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014; 88(19):11034-44. PMC: 4178831. DOI: 10.1128/JVI.01505-14. View

4.
Le Floch A, Jalil A, Vergnon I, Le Maux Chansac B, Lazar V, Bismuth G . Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J Exp Med. 2007; 204(3):559-70. PMC: 2137907. DOI: 10.1084/jem.20061524. View

5.
Wakim L, Smith J, Caminschi I, Lahoud M, Villadangos J . Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infection. Mucosal Immunol. 2015; 8(5):1060-71. DOI: 10.1038/mi.2014.133. View